Co-codamol side effects, by duration, gender and age (a phase IV clinical study of FDA data)
Summary:
Side effects are reported by people who take Co-codamol (acetaminophen; codeine phosphate). Common side effects include dizziness among females and anxiety among males.
The phase IV clinical study is created by eHealthMe based on 1,873 reports from the FDA, and is updated regularly.
What is Co-Codamol?
Co-codamol has active ingredients of acetaminophen; codeine phosphate. It is often used in pain. eHealthMe is studying from 2,364 Co-codamol users. Check the latest studies of Co-codamol.
1,873 people who take Co-Codamol and have side effects are studied.
What are the common side effects of Co-codamol, by gender? *
What are the common side effects of Co-codamol, by age (0-1 to 60+)? *
What are the common side effects of Co-codamol, by the time people have been on the drug (< 1 month to 10+ years)? *
* Approximation only. Some reports may have incomplete information.
Do you take Co-codamol?
- Personalize this study to your gender and age- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
How the study uses the data?
The study is based on acetaminophen; codeine phosphate (the active ingredients of Co-codamol) and Co-codamol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies are listed below in case you need more information:
Alternative drugs to, pros and cons of Co-codamol:
- Co-codamol (2,364 reports)
All Co-codamol side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Arava cause Terminal State? - 6 seconds ago
- Valacyclovir Hydrochloride and Fludarabine Phosphate drug interactions for men aged 40-49 - 8 seconds ago
- Fatigue in Apresoline, how severe and when it was recovered? - 40 seconds ago
- Drug interactions of Methadone Hydrochloride and Heparin Sodium - 41 seconds ago
- Could Fluoride cause Haemoglobin Decreased? - 48 seconds ago
- Dry Skin in Zenatane, how severe and when it was recovered? - 51 seconds ago
- Systemic Lupus Erythematosus and Hypotension - 56 seconds ago
- Ipratropium Bromide and Serotonin Syndrome for Women aged 50-59 - 57 seconds ago
- Ipratropium Bromide and Serotonergic Syndrome for Women aged 50-59 - 57 seconds ago
- Ipratropium Bromide and Hyperserotonemia for Women aged 50-59 - 57 seconds ago